InvestorsHub Logo
Followers 21
Posts 12423
Boards Moderated 3
Alias Born 07/06/2003

Re: pennstreet post# 43677

Tuesday, 09/02/2014 12:20:36 PM

Tuesday, September 02, 2014 12:20:36 PM

Post# of 45771

Having said that, we will not have to wait but 3 to 4 weeks, to see if any lender's research team feels the products at Cdex are worth the risk to lend dollars.



The lenders are interested in only one thing, making a profit.

Making a profit from trading shares as did GEMINI, or actually expecting a profit from sales of some product.

ELEMENTAL market research from what is now known would rule against expecting a profit from the G4. A niche thing even if it works, with a lack of prospective sales.

Now if the CDEX Doc pitches that the G4 or a watered down version would greatly simplify analysis of LAB WORK on Blood, Urine, ETC samples, including DNA to establish parentage etc, and can convince them from that angle then it could work.

The GUDE DOC did recently buy him a pile more shares as was reported to the SEC. Plus he owns LABS. And can open many more if it becomes profitable enough.

Any lender would likely require much more control and may even demand a new and actually qualified CEO as well as a seat on the BOD.

BUT we shall see.

Ole Crowe

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.